Abolis Biotechnologies brings French industrial biotech excellence to Saudi Arabia, driving the Kingdom’s shift toward a sustainable and sovereign bioeconomy - a momentum reinforced by its participation in the Booster Grow Global KSA program.
As part of the « Important Project of Common European Interest » (IPCEI) in the field of healthcare, the Med4Cure program includes public support of up to €140 million under France 2030.
At Abolis Biotechnologies, we believe that innovation doesn’t stop at the laboratory door. That’s why we’re excited to introduce our new website, redesigned to better reflect who we are today, our vision, and how we contribute to a more sustainable bioeconomy with solutions tailored to your needs.
Abolis Biotechnologies secures 35 Mio. Euro from International Consortium of Industrials and Funds
We are dedicated to pioneering sustainable and innovative solutions for the beauty and personal care industry. We are thrilled to highlight our partnership with Abolis, which enhances our commitment to leveraging biotechnology in our formulations.
Abolis, a proud member of @Genopole, is excited to join the Business France delegation at BIO International Convention 2025! We will be showcasing cutting-edge microbial biotechnology and our Microbiome Studio solutions.